Sigyn Therapeutics (SIGY) News Today $3.00 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesSEC FilingsBuy This Stock SIGY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Sigyn Therapeutics (OTCMKTS:SIGY) Trading Down 5.4% - Should You Sell?August 19, 2025 | americanbankingnews.comSigyn Therapeutics Secures Convertible Note AgreementAugust 15, 2025 | msn.comSigyn Therapeutics Delays 10-Q FilingAugust 15, 2025 | tipranks.comSigyn Therapeutics Delays Q1 2025 10-Q FilingMay 15, 2025 | tipranks.comSigyn Therapeutics Delays Yearly Report FilingMarch 31, 2025 | tipranks.comSigyn CEO Note: An Emerging New Industry, 15 Years in the MakingMarch 12, 2025 | finance.yahoo.comSigyn CEO Note: Combating the Rising Threat of New Pandemic VirusesMarch 5, 2025 | finance.yahoo.comSigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare AnalystFebruary 25, 2025 | finance.yahoo.comSigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor ConferenceFebruary 5, 2025 | financialpost.comFSigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor ConferenceFebruary 5, 2025 | globenewswire.comSigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of DirectorsJanuary 29, 2025 | finance.yahoo.comSigyn Therapeutics, Inc. (SIGY)December 21, 2024 | finance.yahoo.comPresenting on the Emerging Growth Conference 76 Day 2 on October 31 Register NowOctober 30, 2024 | markets.businessinsider.comPresenting on the Emerging Growth Conference 74 Day 2 on August 22 Register NowAugust 21, 2024 | finance.yahoo.comOTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand ViewingAugust 2, 2024 | finance.yahoo.comSigyn Therapeutics Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comSigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"May 7, 2024 | finance.yahoo.comSigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth ConferenceMarch 5, 2024 | finance.yahoo.comSigyn Therapeutics to Present at Tomorrow's Emerging Growth ConferenceMarch 5, 2024 | finance.yahoo.comSigyn Therapeutics™ to Present at Tomorrow's Emerging Growth ConferenceMarch 5, 2024 | globenewswire.comSigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-KFebruary 21, 2024 | globenewswire.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Completes Reverse Stock SplitFebruary 2, 2024 | finanznachrichten.deSigyn Therapeutics Announces 1-for-40 Reverse Stock SplitFebruary 1, 2024 | msn.comSigyn Therapeutics Completes Reverse Stock SplitFebruary 1, 2024 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Releases Letter to ShareholdersJanuary 30, 2024 | finanznachrichten.deEQS-News: Sigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | markets.businessinsider.comSigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | finance.yahoo.comSigyn Therapeutics Releases Letter to ShareholdersJanuary 4, 2024 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial OfficerDecember 12, 2023 | finanznachrichten.deSigyn Therapeutics appoints Jerry DeCiccio as finance chiefDecember 12, 2023 | msn.comSigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial OfficerDecember 12, 2023 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finanznachrichten.deSigyn Therapeutics Inc GAAP EPS of -$0.02November 15, 2023 | msn.comSigyn Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comSigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment ToxicityOctober 4, 2023 | finance.yahoo.comSigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association ConferenceSeptember 15, 2023 | finance.yahoo.comRelay Therapeutics Inc Ordinary SharesJune 23, 2023 | morningstar.comMBeam Therapeutics (NASDAQ: BEAM)May 21, 2023 | fool.comSigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark ApplicationMay 17, 2023 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports First Quarter 2023 Financial ResultsMay 16, 2023 | finanznachrichten.deSigyn Therapeutics Reports First Quarter 2023 Financial ResultsMay 16, 2023 | finance.yahoo.comSigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific OfficerApril 11, 2023 | finance.yahoo.comSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KMarch 31, 2023 | finance.yahoo.comChinook TherapeuticsMarch 21, 2023 | forbes.comJounce Therapeutics downgraded to market perform at Raymond James on company restructuringFebruary 25, 2023 | seekingalpha.com Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address SIGY Media Mentions By Week SIGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SIGY News Sentiment▼0.000.69▲Average Medical News Sentiment SIGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SIGY Articles This Week▼10▲SIGY Articles Average Week Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies enVVeno Medical News NexGel News Femasys News Nexalin Technology News NeurAxis News Allurion Technologies News Inspira Technologies OXY B.H.N. News DIH Holding US News Meihua International Medical Technologies News Intelligent Bio Solutions News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SIGY) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigyn Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sigyn Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access